Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Heregulin beta 1 Protein

Spezies: Human Wirt: Escherichia coli (E. coli) Recombinant < 98 % by SDS-PAGE gel and HPLC analyses. Active
Produktnummer ABIN2468517
  • Target Alle Heregulin beta 1 Produkte
    Heregulin beta 1
    Protein-Typ
    Recombinant
    Biologische Aktivität
    Active
    Spezies
    Human
    Quelle
    • 1
    Escherichia coli (E. coli)
    Sequenz
    SHLVKCAEKE KTFCVNGGEC FMVKDLSNPS RYLCKCPNEF TGDRCQNYVM ASFYKHLGIE FMEAE
    Produktmerkmale
    The ED50 was determined by the dose - dependent stimulation of the proliferation of human MCF - 7 cells is < 0.5 ng/mL, corresponding to a specific activity of > 2 x 106 units/mg.
    Reinheit
    < 98 % by SDS-PAGE gel and HPLC analyses.
    Endotoxin-Niveau
    Endotoxin level is less than 0.1 ng per μg (1 EU/μg).
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Handhabung
    As with any protein, exposing Heregulin-B1 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    The recombinant protein is stable for at least 2 years from date of receipt at -20 °C. Reconstituted Heregulin-B1 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20 °C.
    Haltbarkeit
    24 months
  • Target
    Heregulin beta 1
    Abstract
    Heregulin beta 1 Produkte
    Hintergrund
    Neuregulin/Heregulin is a family of structurally related polypeptide growth factors derived from alternatively spliced genes (NRG1, NRG2, NRG3 and NRG4). To date, there are over 14 soluble and transmembrane proteins derived from the NRG1 gene. Proteolytic processing of the extracellular domain of the transmembrane NRG1 isoforms release soluble growth factors. HRG1-beta1 contains an Ig domain and an EGF-like domain that is necessary for direct binding to receptor tyrosine kinases erb3 and erb4. This binding induces erb3 and erb4 heterodimerization with erb2, stimulating intrinsic kinase activity, which leads to tyrosine phosphorylation. Although HRG1-beta1 biological effects is still unclear, it has been found to promote motility and invasiveness of breast cancer cells which may also involve up-regulation of expression and function of the autocrine motility-promoting factor (AMF). Recombinant human Heregulin-beta1 (HRG1-beta1) is a 7.5 kDa polypeptide consisting of only the EGF domain of heregulin-beta1 (65 amino acid residues).
    Gen-ID
    3084
    NCBI Accession
    NP_001153468
    OMIM
    236461846
    UniProt
    Q02297
Sie sind hier:
Kundenservice